Cargando…
Neuromodulation, Emotional Feelings and Affective Disorders
Affective disorders such as anxiety, phobia and depression are a leading cause of disabilities worldwide. Monoamine neuromodulators are used to treat most of them, with variable degrees of efficacy. Here, we review and interpret experimental findings about the relation of neuromodulation and emotion...
Autores principales: | Wang, Fushun, Pereira, Alfredo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5179628/ https://www.ncbi.nlm.nih.gov/pubmed/28031622 http://dx.doi.org/10.4103/0973-1229.154533 |
Ejemplares similares
-
Neuromodulator and Emotion Biomarker for Stress Induced Mental Disorders
por: Gu, Simeng, et al.
Publicado: (2016) -
Emotion Induced Monoamine Neuromodulator Release Affects Functional Neurological Disorders
por: Liang, Fei, et al.
Publicado: (2021) -
Feelings and Emotions
por: Buxton, Claude C.
Publicado: (1954) -
Psychology of Feeling and Emotion
por: Edgell, Beatrice
Publicado: (1937) -
Monoamine Neurotransmitters Control Basic Emotions and Affect Major Depressive Disorders
por: Jiang, Yao, et al.
Publicado: (2022)